 | Novo Nordisk A/S | |||
| NYQ : NVO || Location: Denmark | ||||
$128.64+3.38 (+2.7%) |
3.7 M | 126.34 - 128.76 | ||
| Last Updated:America/New_York | Volume | Day range |
Short Interest
| Short Date | Short Interest |
|---|---|
| March 28, 2024 | 2.833 M |
| March 15, 2024 | 4.109 M |
| Feb. 29, 2024 | 4.668 M |
| Feb. 15, 2024 | 7.518 M |
| Jan. 31, 2024 | 5.458 M |
EPS Surprise
| Period | Estimate | Actual | Surprise |
|---|---|---|---|
| 12/31/2023 | 4.58 | 4.91 | 7.31% |
| 06/30/2023 | 4.62 | 4.32 | -6.63% |
| 03/31/2023 | 4.30 | 4.39 | 2.11% |
| 12/31/2022 | 2.93 | 3.01 | 2.85% |
| 09/30/2022 | 0.90 | 0.91 | 1.10% |
Recent Dividends
| Div Date | Div Amount |
|---|---|
| 03/22/2024 | 0.93 |
| 08/18/2023 | 0.88 |
| 03/24/2023 | 1.19 |
| 08/12/2022 | 0.58 |
| 03/25/2022 | 1.02 |
NVO Basic Data
| Sector | Healthcare | Industry | Biotechnology |
| Shares Outstanding | 4461.530M | Shares Float | 3192.892M |
| Short Float | 2.833M | Market Cap | 573931.22M |
| Institution ownership | 9.32% | Insider ownership | 0.004% |
| Earnings Date | Cash Per Share | ? | |
| Trailing EPS | 2.66 | Forward EPS | 4.00 |